基于新型quinazolin-4(3H) -one的Cyclin K降解剂调节了替代的多基化活性
Osamu Sano1, Masahiro Ito1, Masayo Saito1
1Research, Takeda Pharmaceutical Company, Fujisawa, Kanagawa, Japan.
Biochemical and biophysical research communications
|July 22, 2023
概括
现型查确定了T4,一种新型分子,可降解Cyclin K并调节替代多化. 为了进一步研究,开发了一种更强大的降解剂TR-213.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 化学生物学 化学生物学
背景情况:
- 表型查是发现具有新作用机制的化合物的关键方法.
- 通过表型查识别的分子,通过形成E3联酶三元复合体来诱导蛋白降解.
- 替代多基化 (APA) 是一个关键的转录后调节过程.
研究的目的:
- 通过表型查识别调节细胞表型的新型化合物.
- 通过表型查确定了一种新的Cyclin K降解剂的作用机制.
- 开发改进的化学工具来研究循环K降解和APA调节.
主要方法:
- 全球蛋白质组分析以确定蛋白质降解剂.
- 对调节替代多基化的化合物进行表型选.
- 确定化合物-标相互作用的机制研究.
- 结构-活性关系 (SAR) 研究以优化化合物的效力.
主要成果:
- 一种新的分子,T4,通过表型查被确定为cyclin k降解剂.
- 证实T4诱导了Cyclin K的降解,从而调节了替代的多基化.
- 一种更强大的环林K降解剂TR-213是基于T4的SAR研究合成的.
- T4和TR-213在结构上与现有的Cyclin K降解剂有所区别.
结论:
- T4代表了一种新的化学工具,用于研究循环K的功能及其在APA中的作用.
- TR-213为研究Cyclin K降解途径提供了增强的功效.
- 这些化合物为探索针对蛋白质降解的治疗潜力提供了新的途径.
更多相关视频
10:33Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
Published on: October 26, 2015
11.4K
10:54Studying Proteolysis of Cyclin B at the Single Cell Level in Whole Cell Populations
Published on: September 17, 2012
10.6K
相关概念视频
Inhibition of Cdk Activity
4.8K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
Positive Regulator Molecules
5.5K
Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
5.5K
Anaphase Promoting Complex
2.9K
The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
2.9K
Negative Regulator Molecules
35.5K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.5K
M-Cdk Drives Transition Into Mitosis
5.6K
Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
5.6K
Nuclear Export of mRNA
7.7K
Before mRNAs are exported to the cytoplasm, it is crucial to check each mRNA for structural and functional integrity. Eukaryotic cells use several different mechanisms, collectively known as mRNA surveillance, to look for irregularities in mRNAs. Irregular or aberrant mRNA are rapidly degraded by various enzymes. If a defective mRNA escapes the surveillance, it would be translated into a protein which would either be non-functional or not function properly. One of the primary irregularities in...
7.7K
